title: Predicting the response to infliximab from trough serum levels.
authors.affiliation: Department of Medicine, Division of Gastroenterology, University of Leuven, Herestraat 49, 3052 Leuven, Belgium. paul.rutgeerts@uz.kuleuven.ac.be
authors.forename: Paul
authors.initials: P
authors.lastname: Rutgeerts
authors.forename: Severine
authors.initials: S
authors.lastname: Vermeire
authors.forename: Gert
authors.initials: G
authors.lastname: Van Assche
mesh_terms: D000911:Antibodies, Monoclonal / Q000097:blood* / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000097:blood / Q000188:drug therapy*; D016903:Drug Monitoring / Q000379:methods*; D005765:Gastrointestinal Agents / Q000097:blood* / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab